Pfizer's vaccine is over 90 percent effective against symptomatic COVID-19 in kids

Pfizer
(Image credit: Mario Tama/Getty Images)

Pfizer's vaccine was found to be more than 90 percent effective against symptomatic COVID-19 in children between the ages of 5 and 11, the company says.

Pfizer and BioNTech released the new data on Friday from a trial that included about 2,000 children after previously seeking FDA emergency authorization to administer its COVID-19 vaccine to kids, CNN reports. The company said the vaccine was shown to be safe and 90.7 percent effective against symptomatic COVID-19 in children aged 5 to 11. The Pfizer vaccine is fully approved for those 16 and older and has also been authorized for those between 12 and 15.

Subscribe to The Week

Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

SUBSCRIBE & SAVE
https://cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516.jpg

Sign up for The Week's Free Newsletters

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

Sign up
Brendan Morrow

Brendan worked as a culture writer at The Week from 2018 to 2023, covering the entertainment industry, including film reviews, television recaps, awards season, the box office, major movie franchises and Hollywood gossip. He has written about film and television for outlets including Bloody Disgusting, Showbiz Cheat Sheet, Heavy and The Celebrity Cafe.